Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/12/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Ronald C. Hendrickson

Wrong Dr. Ronald C. Hendrickson?

Laboratory Member and Head of Pro...

Memorial Sloan-Kettering Cancer Center
1275 York Avenue Box # 460
New York, New York 10065
United States

Company Description: Memorial Sloan-Kettering Cancer Center is the world's oldest and largest institution devoted to prevention, patient care, research and education in cancer. Our...   more
Background

Employment History

Education

  • Ph.D.
31 Total References
Web References
CHI, Cambridge Healthtech Institute - Protein Biomarkers 2006
www.healthtech.com, 1 Jan 2006 [cached]
Ronald C. Hendrickson, Ph.D., Director, MP Proteomics, Merck Research Labs
Keynote Speakers
www.adaptcongress.com, 26 June 2009 [cached]
Ronald C. Hendrickson, Ph.D., Head, Proteomics, Molecular Profiling, Merck Research Labs
About Us | Rosetta Biosoftware
www.rosettabio.com, 12 Dec 2008 [cached]
Dr. Ronald C. Hendrickson, is the director of Proteomics in the department of Molecular Profiling at Merck Research Laboratories in Rahway, New Jersey, USA. Currently, he is applying state-of-the-art mass spectrometry techniques to rapidly identify and quantify changes in proteins related to disease or therapeutic agents. Prior to joining Merck, Dr. Hendrickson served as a Vice President for MDS Proteomics (Protana), a leading proteomics company founded on emerging informatics tools and nano-electrospray technology developed the EMBL. He also served as Chairman of the MDS Proteomics-Harvard Partners Joint Steering Committee. This strategic alliance was established to combine the collective expertise of clinical investigators and state of the art proteomics to speed the discovery, development and commercialization of innovative healthcare products.
Dr. Hendrickson joined Protana in Odense Denmark to work with Matthias Mann and Ole Vorm At Protana, his research efforts expanded into large-scale protein-protein interaction studies using yeast as a model organism.
...
Prior to joining Protana, Dr. Hendrickson was employed by Corixa Corporation in Seattle, Washington, USA. His research at Corixa involved identifying tumor antigens and serological markers for Breast cancer and Tuberculosis.
Dr. Hendrickson received his B.S. in Chemistry from the University of Washington and his Ph.D. in Chemistry from the University of Virginia. Under the guidance of Professor Donald F. Hunt, Dr. Hendrickson developed and applied high-sensitivity mass spectrometry to biological research.
Rosetta Biosoftware
www.rosettainpharmatics.com, 5 Dec 2007 [cached]
Dr. Ronald C. Hendrickson, is the director of Proteomics in the department of Molecular Profiling at Merck Research Laboratories in Rahway, New Jersey, USA.Currently, he is applying state-of-the-art mass spectrometry techniques to rapidly identify and quantify changes in proteins related to disease or therapeutic agents.Prior to joining Merck, Dr. Hendrickson served as a Vice President for MDS Proteomics (Protana), a leading proteomics company founded on emerging informatics tools and nano-electrospray technology developed the EMBL.He also served as Chairman of the MDS Proteomics-Harvard Partners Joint Steering Committee.This strategic alliance was established to combine the collective expertise of clinical investigators and state of the art proteomics to speed the discovery, development and commercialization of innovative healthcare products.
Dr. Hendrickson joined Protana in Odense Denmark to work with Matthias Mann and Ole Vorm At Protana, his research efforts expanded into large-scale protein-protein interaction studies using yeast as a model organism.
...
Prior to joining Protana, Dr. Hendrickson was employed by Corixa Corporation in Seattle, Washington, USA.His research at Corixa involved identifying tumor antigens and serological markers for Breast cancer and Tuberculosis.
Dr. Hendrickson received his B.S. in Chemistry from the University of Washington and his Ph.D. in Chemistry from the University of Virginia.Under the guidance of Professor Donald F. Hunt, Dr. Hendrickson developed and applied high-sensitivity mass spectrometry to biological research.
CPSA
www.milestonedevelopment.com, 1 Jan 2009 [cached]
Ron Hendrickson, Merck Research Laboratories
Other People with the name "Hendrickson":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304